AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway

Area of Science:

• Endocrinology
• Cardiovascular Biology
• Cellular Biology

Background:

• Diabetes mellitus accelerates the formation of advanced glycation end products (AGEs).
• AGEs are frequently detected in circulating endothelial microparticles (EMPs), suggesting a link to endothelial dysfunction.

Purpose of the Study:

• To determine if AGEs directly induce EMP formation.
• To elucidate the underlying molecular mechanisms of AGE-induced EMP generation.

Main Methods:

• Human umbilical vein endothelial cells (HUVECs) were treated with varying concentrations of AGEs in vitro.
• Cells were pretreated with anti-RAGE antibody, NAD(P)H oxidase (NOX) inhibitor, or reactive oxygen species (ROS) scavenger.
• Endothelial microparticle (EMP) levels were quantified using flow cytometry.

Main Results:

• AGEs significantly increased EMP numbers in a dose-dependent manner.
• AGEs upregulated the expression of RAGE, NOX, and ROS.
• Inhibition of RAGE, NOX, or ROS attenuated AGE-induced EMP formation.

Conclusions:

• Advanced glycation end products (AGEs) directly promote endothelial microparticle (EMP) generation.
• The AGE-induced EMP increase is mediated by RAGE signaling via NOX-dependent ROS production.
• Targeting RAGE or ROS pathways may offer therapeutic strategies for diabetic complications.